The 24th August 2023 start date for the REACH training and certification requirements for users of diisocyanates is looming ever closer, impacting the use of many polyurethane adhesives in medical applications.
Injection moulding is the preferred method for mass-producing precision plastic parts. However, its upfront costs can be hefty. It’s worthwhile to tweak the production process to decrease both the complexity and the overall expense of a project.
BHTA outlines three key questions for the Government on behalf of the healthcare manufacturing sector to deliver the future of medical device regulation in the UK, following confusion over CE mark recognition in the UK.
The global heart monitoring devices market valuation stands at US$ 25 billion in 2023 and is projected to reach US$ 45 billion by 2033. Worldwide demand for heart monitoring devices is forecasted to increase at a CAGR of 6% from 2023 to 2033.
Kevin Brownsill, head of technical: learning and development at Intertronics, discusses how temporary masking challenges can be overcome with UV curable materials.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, chair of the Urology Trade Association, trustee of the Institute of Medical Ethics and a governor of the Anscombe Bioethics Centre, updates readers on the MHRA and post-Brexi
Kevin Brownsill, head of technical: learning and development of adhesives specialist Intertronics, discusses the chemistry of PUs and how new REACH requirements will impact manufacturers.
Helen Henderson, senior associate, life sciences and chemistry team and Bethan Halliwell, partner, electronics, computing and physics team, Withers & Rogers discusses how to combat non-adherence with technology.
After the University of Portsmouth announced a new ‘stealth’ polymer, Medical Plastics News spoke to Dr Farah El Mohtadi, senior lecturer in pharmaceutical sciences for the School of Pharmacy and Biomedical Sciences, for more information.
With Industry 4.0 quickly becoming an established reality, biopharmaceutical R&D, manufacturing and quality control facilities are implementing novel sensors and analysers that generate complex data.
